Direct comparison
Option Agreement vs. License Agreement
An option agreement grants only the exclusive right to negotiate a license. A license agreement grants actual rights to use the technology. Key differences.
Written and maintained by CASRAI Editorial Board
Last updated
Ask CASRAI · included with Regulatory Radar
Ask about Option Agreement vs. License Agreement
Ask CASRAI answers research-administration questions and cites the passages behind every claim — and says so when the corpus does not cover something, instead of guessing. It comes with a Regulatory Radar subscription at $29 a month, alongside the daily digest of regulatory changes and the dashboard of what changed.
150 questions a day, on this site, over the API, or inside your own tools through the CASRAI MCP server.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.
How do Option Agreement, License Agreement compare side by side?
The table below compares Option Agreement, License Agreement across 8 procurement-relevant dimensions, from what it grants through relationship to an evaluation agreement.
Side-by-side comparison
| Dimension | Option Agreement | License Agreement |
|---|---|---|
| What it grants | Exclusive right to negotiate a license within a set period | Actual rights to make, use, sell, or sublicense the technology |
| Right to use the technology | No, unless a separate evaluation agreement or license is also in place | Yes, within the scope negotiated (field of use, territory, exclusivity) |
| Typical duration | A few months to about a year, sometimes longer with milestones | Can run for the life of the underlying patent or longer for know-how/trade secrets |
| Typical fee structure | Option fee plus reimbursement of patent prosecution costs during the option period | Upfront fee, running royalties, milestone payments, and/or equity, depending on terms |
| Exclusivity | Exclusivity applies to negotiation only -- the institution cannot shop the technology to others during the option period | Exclusivity (if any) applies to the actual commercialization rights granted, defined by field of use and territory |
| When it is used | Early-stage companies, often pre-financing, that need time before committing to full license negotiation | Once the parties are ready to commit to defined commercialization terms |
| What happens at expiration | If unexercised, the institution is generally free to market the technology to other parties | Governed by the license’s own term, termination, and diligence clauses |
| Relationship to an evaluation agreement | Often signed alongside or after an evaluation agreement, which separately grants limited testing rights | Typically the end point of the pipeline, following evaluation and/or option stages |
Common questions
Common questions about Option Agreement vs License Agreement
Can an option agreement include any right to use the technology?
+
Not by default. An option agreement’s core grant is negotiation exclusivity, not use rights. If a prospective licensee also needs to test or benchmark the technology, that typically requires a separate evaluation agreement.
Is an option agreement the same as a right of first negotiation or first refusal?
+
Related but not identical. A right of first negotiation typically requires the institution to negotiate with the option holder first, without necessarily foreclosing negotiation with a third party if those talks fail. A fully exclusive option forecloses negotiation with anyone else during the option period. The exact scope depends on the specific agreement’s language.
Do institutions charge for an option agreement?
+
Most option agreements include an option fee plus reimbursement of the institution’s patent prosecution costs during the option period, since the institution is giving up the ability to shop the technology to other prospective licensees for that duration.
Why would a startup want an option instead of just negotiating the license directly?
+
Speed and cost. An option agreement is a shorter, cheaper document to negotiate than a full license, and it lets an early-stage company secure its IP position — something investors typically want to see before committing funding — before spending the time and legal cost a full license negotiation requires.
Going deeper
